Evaluation du bénéfice apporté par une diminution des doses de ciclosporine et l'adjonction de mycophénolate mofétil chez les transplantés cardiaques afin de réduire la morbidité du traitement immunosuppresseur

Résumé Les patients ayant subi une transplantation cardiaque nécessitent un traitement immunosuppresseur à vie. Or un tel traitement entraîne différents effets secondaires, en fonction du médicament et des doses utilisés. La ciclosporine, connue pour sa puissante action immunosuppressive, est utilisée chez ces patients avec grand succès. Ainsi, ces dernières années, on a assisté à une diminution de la morbidité et de la mortalité post- transplantation. Ce succès s'accompagne toutefois d'effets secondaires, qui s'expriment principalement par une hypertension artérielle (HTA) et une dysfonction rénale voire une insuffisance rénale (augmentation de la créatinine et diminution de la clearance de la créatinine). L'introduction d'un nouvel immunosuppresseur, le mycophénolate mofétil (MMF, Cellcept), qui remplace l'azathioprine (AZA), a permis une réduction importante des doses de ciclosporine de 3-5mg/l(g/j à 1- 3mg/l(g/j. Or certaines études ont permis d'observer que l'utilisation du MMF associé à de faibles doses de ciclosporine après la transplantation entraîne une meilleure évolution chez les patients, notamment pour ce qui est de la tension artérielle (TA) et de la fonction rénale. Objectifs Il s'agit de déterminer l'influence, dans le temps, du MMF associé à de faibles doses de ciclosporine sur la TA et la fonction rénale chez les patients transplantés cardiaques, dans deux cas de figure: d'une part lorsque le traitement est commencé immédiatement après la transplantation, d'autre part lorsqu'il n'est introduit qu'une fois la détérioration de la fonction rénale apparue. Patients et méthodes La présente analyse rétrospective porte sur 105 patients ayant subi une transplantation cardiaque au CHUV de Lausanne, évalués un an après la greffe. Les patients ont été subdivisés en 3 groupes. Le groupe 1(67 patients) a reçu de la ciclosporine à doses conventionnelles (3-5mg11<g/j) et de l'azathioprine dès la transplantation. Les patients du groupe II (30 personnes) ont également reçu de la ciclosporine et de l'azathioprine, mais, en raison d'une détérioration rénale progressive, de myalgies ou d'arthralgies secondaires à la ciclosporine, ont bénéficié d'une modification du traitement consistant en une réduction des doses de ciclosporine en association avec du MMF (2gr1j) à la place de l'azathioprine. Enfin, les patients du groupe III (8 patients suivis pendant 2 ans maximum), ont reçu, dès la transplantation, du MMF (2g/D associé à de faibles doses de ciclosporine (jusqu'à 50% de moins que la dose conventionnelle, c'est-à-dire entre 1,0 et 1,5 meg/j). La TA, la créatinine, la clearance de la créatinine, l'incidence des infections et des rejets ont été analysées. Résultats La TA et la créatinine ont augmenté significativement au cours de la première année dans les 3 groupes, sans différences significatives entre ceux-ci. Pendant 5 ans, l'évolution des groupes I et II est restée similaire. Dans le groupe II, aucune amélioration de la créatinine et de la tension artérielle n'a été observée après la modification du traitement. Le groupe III, en revanche, a montré une très claire diminution de l'incidence des rejets aigus, aucun décès et une tendance (non significative) à une meilleure évolution de la créatinine et de la tension artérielle au cours de la première année en comparaison avec les groupes I et II. En ce qui concerne l'incidence des infections, il n'y a pas de différences entre les 3 groupes. Conclusion Une fois qu'une détérioration importante de la fonction rénale est apparue suite à l'administration de doses conventionnelles de ciclosporine, il est peu probable de réussir à récupérer la fonction rénale par une modification du traitement (MMF et faibles doses de ciclosporine), car le rein n'a plus de tissu fonctionnel de réserve. Le traitement associant le MMF à de faibles doses de ciclosporine administré dès la transplantation ayant montré une tendance à une meilleure évolution, notamment à une réduction de l'incidence des rejets (importante cause de mortalité) au cours de la première année, nous pensons que ce nouveau régime de traitement peut être plus bénéfique pour les patients s'il est introduit rapidement après la transplantation.

Effect of treatment with cyclophosphamide in low doses upon the onset of delayed type hypersensitivity in mice chronically infected with Trypanosoma cruzi: involvement of heart interstitial dendritic cells

Acute infection with Trypanosoma cruzi results in intense myocarditis, which progresses to a chronic, asymptomatic indeterminate form. The evolution toward this chronic cardiac form occurs in approximately 30% of all cases of T. cruzi infection. Suppression of delayed type hypersensitivity (DTH) has been proposed as a potential explanation of the indeterminate form. We investigated the effect of cyclophosphamide (CYCL) treatment on the regulatory mechanism of DTH and the participation of heart interstitial dendritic cells (IDCs) in this process using BALB/c mice chronically infected with T. cruzi. One group was treated with CYCL (20 mg/kg body weight) for one month. A DTH skin test was performed by intradermal injection of T. cruzi antigen (3 mg/mL) in the hind-footpad and measured the skin thickness after 24 h, 48 h and 72 h. The skin test revealed increased thickness in antigen-injected footpads, which was more evident in the mice treated with CYCL than in those mice that did not receive treatment. The thickened regions were characterised by perivascular infiltrates and areas of necrosis. Intense lesions of the myocardium were present in three/16 cases and included large areas of necrosis. Morphometric evaluation of lymphocytes showed a predominance of TCD8 cells. Heart IDCs were immunolabelled with specific antibodies (CD11b and CD11c) and T. cruzi antigens were detected using a specific anti-T. cruzi antibody. Identification of T. cruzi antigens, sequestered in these cells using specific anti-T. cruzi antibodies was done, showing a significant increase in the number of these cells in treated mice. These results indicate that IDCs participate in the regulatory mechanisms of DTH response to T. cruzi infection.

Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate

Meglumine antimoniate (MA) and sodium stibogluconate are pentavalent antimony (SbV) drugs used since the mid-1940s. Notwithstanding the fact that they are first-choice drugs for the treatment of leishmaniases, there are gaps in our knowledge of their toxicological profile, mode of action and kinetics. Little is known about the distribution of antimony in tissues after SbV administration. In this study, we evaluated the Sb content of tissues from male rats 24 h and three weeks after a 21-day course of treatment with MA (300 mg SbV/kg body wt/d, subcutaneous). Sb concentrations in the blood and organs were determined by inductively coupled plasma-mass spectrometry. In rats, as with in humans, the Sb blood levels after MA dosing can be described by a two-compartment model with a fast (t1/2 = 0.6 h) and a slow (t1/2 >> 24 h) elimination phase. The spleen was the organ that accumulated the highest amount of Sb, while bone and thyroid ranked second in descending order of tissues according to Sb levels (spleen >> bone, thyroid, kidneys > liver, epididymis, lungs, adrenals > prostate > thymus, pancreas, heart, small intestines > skeletal muscle, testes, stomach > brain). The pathophysiological consequences of Sb accumulation in the thyroid and Sb speciation in the liver, thyroid, spleen and bone warrant further studies.

Estimation de la fonction rénale par l'equation MDRD: intérêt et limites pour l'adaptation des doses de médicaments [Renal function estimation by MDRD equation: interest and limitations for drug dosing].

The MDRD (Modification of diet in renal disease) equation enables glomerular filtration rate (GFR) estimation from serum creatinine only. Thus, the laboratory can report an estimated GFR (eGFR) with each serum creatinine assessment, increasing therefore the recognition of renal failure. Predictive performance of MDRD equation is better for GFR < 60 ml/min/1,73 m2. A normal or near-normal renal function is often underestimated by this equation. Overall, MDRD provides more reliable estimations of renal function than the Cockcroft-Gault (C-G) formula, but both lack precision. MDRD is not superior to C-G for drug dosing. Being adjusted to 1,73 m2, MDRD eGFR has to be back adjusted to the patient's body surface area for drug dosing. Besides, C-G has the advantage of a greater simplicity and a longer use.

Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers.

Plasma concentrations of the enantiomers of fluoxetine (FLX) and norfluoxetine (NFLX) were measured at days 7, 14, and 23 of oral administration of 20 mg of racemic fluoxetine in 11 patients who were comedicated with risperidone. Eight patients were genotyped as being cytochrome P4502D6 extensive metabolizers (EMs) and three as cytochrome P4502D6 poor metabolizers (PMs). No statistically significant differences were calculated between EMs and PMs in the concentrations of (R)-FLX and (R)-NFLX for all days examined (day 23, mean +/- SD for (R)-FLX and (R)-NFLX in EMs, 16 +/- 5 and 29 +/- 20 ng/mL, respectively; in PMs, 16 +/- 1 and 20 +/- 2 ng/mL, respectively). However, concentrations of (S)-FLX and (S)-NFLX were higher and lower, respectively, in PMs as compared with EMs (day 7, p = 0.037 and p = 0.036; day 14, p = 0.014 and p = 0.014; day 23, p = 0.068 and p = 0.038). On day 23, mean (S)-FLX and (S)-NFLX in EMs were (mean +/- SD) 39 +/- 26 and 63 +/- 26 ng/mL, and in PMs they were 88 +/- 7 and 19 +/- 2 ng/mL. This study confirms the results of the single-dose studies showing that CYP2D6 is involved in the demethylation of FLX to NFLX, with a stereoselectivity toward the (S)-enantiomer. The data also clearly show that the CYP2D6 genotype has an important influence on the concentrations of the (S)- but not of the (R)-enantiomer of FLX and NFLX after multiple doses.

Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.

We examined in vivo the influence of cytochrome P4503A4 (CYP3A4) activity, measured by the 30 min plasma 1'OH-midazolam/midazolam ratio after oral administration of 7.5 mg midazolam, on the methadone steady-state trough plasma concentrations in a group of 32 patients in methadone maintenance treatment. Patients were grouped as receiving 'low' (up to 99 mg/day, n = 10), 'high' (100-199 mg/day, n = 11) and 'very high' (> or = 200 mg/day, n = 11) doses of methadone, and the CYP3A4 metabolic activity was compared between the three groups. (S)-methadone and (R,S)-methadone, but not (R)-methadone, concentrations to dose ratios significantly correlated with the midazolam ratios (r(2) = -0.17, P = 0.018; r(2) = -0.14, P = 0.032; r(2) = -0.10, P = 0.083, respectively), with a 76% higher CYP3A4 activity in the very high-dose group as compared with the low-dose group. Significant differences in the CYP3A4 activity were calculated between the three groups (P = 0.0036), and group-to-group comparisons, using the Bonferroni correction, showed a significant difference between the low-dose and the very high-dose group (P = 0.0039), between the high-dose and the very high-dose group (P = 0.0064), but not between the low-dose and the high-dose group (P = 0.070). The higher CYP3A4 activity measured in patients receiving very high methadone doses could contribute to the need for higher doses in some patients, due to an increased metabolic clearance. This, however, must be confirmed by a prospective study.

Optimisation des doses en tomographie computérisée pédiatrique [Patient dose optimization in pediatric computerized tomography]

The development of CT applications might become a public health problem if no effort is made on the justification and the optimisation of the examinations. This paper presents some hints to assure that the risk-benefit compromise remains in favour of the patient, especially when one deals with the examinations of young patients. In this context a particular attention has to be made on the justification of the examination. When performing the acquisition one needs to optimise the extension of the volume investigated together with the number of acquisition sequences used. Finally, the use of automatic exposure systems, now available on all the units, and the use of the Diagnostic Reference Levels (DRL) should allow help radiologists to control the exposure of their patients.

Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci.

Recent recommendations for the prophylaxis of endocarditis in humans have advocated single doses or short courses of antibiotic combinations (beta-lactam plus aminoglycoside) for susceptible patients in whom enterococcal bacteremia might develop or for patients at especially high risk of developing endocarditis (e.g., patients with prosthetic cardiac valves). We tested the prophylactic efficacy (in rats with catheter-induced aortic vegetations) of single doses of amoxicillin plus gentamicin against challenge with various streptococcal strains (two strains of Streptococcus faecalis, one of Streptococcus bovis, and three of viridans streptococci); we then compared this efficacy with that of single doses of amoxicillin alone. Successful prophylaxis against all six strains was achieved with single doses of both amoxicillin alone and amoxicillin plus gentamicin. This protection, however, was limited, for both regimens, to the lowest bacterial-inoculum size producing endocarditis in 90% of control rats and was not extended to higher inocula by using the combination of antibiotics. We concluded that a single dose of amoxicillin alone was protective against enterococcal and nonenterococcal endocarditis in the rat, but that its efficacy was limited and could not be improved by the simultaneous administration of gentamicin.

Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

A new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 14824A, was evaluated in 12 healthy male volunteers. Two groups each of 6 volunteers were given 5 or 10 mg once daily p.o. for 8 days. Four hours after the first and the last morning doses, plasma angiotensin II, aldosterone and plasma converting enzyme activity had fallen, while blood angiotensin I and plasma renin activity had risen. Throughout the study, more than 90% inhibition of ACE was found immediately before giving either the 5 or 10 mg dose and 50% blockade was still present 72 h following the last dose. Based on the determination of ACE, there was no evidence of drug accumulation. No significant change in blood pressure or heart rate was observed during the course of the study. CGS 14824A was an effective, orally active, long-lasting and well tolerated converting enzyme inhibitor.

The effect of sub-lethal doses of Azadirachta indica (Meliaceae) oil on the midgut of Spodoptera frugiperda (Lepidoptera, Noctuidae)

The fall armyworm, Spodoptera frugiperda, is one of the major field pests for maize production. It is mainly controlled by means of synthetic, and more recently by resistant cultivar of maize expressing Bt toxins. The neem tree, Azadirachta indica, is a plant that can potentially control insects with the advantage of being food and environmental safe. The aim of this study was to assess the effect of neem oil on the development and survival of S. frugiperda caterpillars by assessing histological alterations caused on their midgut. Newly hatched caterpillars were submitted to three neem oil concentrations: 0.006; 0.05; 0.4%, which were added to their artificial diet. Ten 3rd instar caterpillars, taken from each treatment, were submitted to histological analysis. The alimentary canals from the specimens were fixed in Baker for 12 hours, desiccated and diaphanized in alcohol/xylol (1:1) and xylol. After placing the samples in paraffin, they were sliced in 8 µm sections and stained with hematoxylin-eosin stain. The neem oil added to the diet of S. frugiperda caused total mortality at dose of 0.4% whilst still in the first instars, prolonged the larval and pupal stages, and reduced the pupal weight. Histo-physiological alterations such as degeneration of the epithelial lining of the midgut and in the peritrophic matrix were found at all concentrations of neem oil.

Biomassa microbiana de carbono e de nitrogênio de solos sob diferentes coberturas florestais

O método da fumigação-extração foi utilizado para estimar a biomassa microbiana de carbono (BM-C) e de nitrogênio (BM-N) de um latossolo vermelho-amarelo, sob diferentes coberturas florestais, na região de Viçosa (MG), em amostras de solos coletadas em abril de 1994. Os solos sob eucalipto e pinheiro apresentaram valores maiores de BM-C (223,72 e 207,39 mg kg-1 de C no solo respectivamente) do que os solos sob angico e capoeira (82,94 e 79,47 mg kg-1 de C no solo respectivamen-te). Resultados semelhantes foram obtidos para a serapilheira acumulada. Por outro lado, a taxa de respiração específica da biomassa microbiana (TR-BM) foi maior no solo sob angico e capoeira. A BM-N variou de 8,05 a 16,08 mg kg-1 de N no solo entre as coberturas florestais. A TR-BM apresentou correlação negativa significativa com o N total do solo (r = -0,76**) e com a serapilheira acumulada (r = -0,68*). BM-N apresentou correlação negativa significativa com o N da serapilheira (r = -0,52*) e com o N mineral do solo (r = -0,71*). BM-C, BM-N e respiração acumulada (RA) foram positivamente correlacionadas com o C orgânico (r = 0,63*, r = 0,71* e r = 0,76* respectivamente). O N total correlacionou-se com BM-C e RA (r = 0,77* e r = 0,60* respectivamente). BM-C e BM-N, associadas aos teores de C orgânico, N-total e TR-BM, mostraram ser indicadores sensíveis para aferir a dinâmica desses elementos sob as coberturas vegetais estudadas, mostrando o menor potencial de decomposição da matéria orgânica nos solos sob eucalipto e pinheiro.

Mineralização do nitrogênio incorporado como material vegetal em três solos da Amazônia Central

A mineralização do N proveniente do resíduo de feijão-caupi marcado com 15N foi estudada em condições de laboratório de setembro a dezembro de 1992. O material vegetal foi incorporado em amostras dos três principais solos da Amazônia Central: dois de terra firme, classificados como latossolo amarelo e podzólico vermelho-amarelo, e um de várzea, classificado como glei pouco húmico (GP). As variações nos teores e na forma de N mineral provenientes do resíduo de caupi foram relacionadas com as características químicas dos solos estudados. No latossolo e no podzólico, a incorporação do resíduo de caupi aumentou significativamente a mineralização do N, sendo a forma amoniacal predominante, enquanto, no GP, a forma nítrica preponderou. Nos solos de terra firme, a incorporação do resíduo de caupi aumentou a mineralização do N orgânico do solo, indicando a ocorrência do efeito "priming". Após 60 dias de incubação, cerca de 30 (podzólico) a 40% (latossolo) do N proveniente do caupi foi mineralizado nos solos de terra firme, enquanto no de várzea somente 18% foi mineralizado nesse período. Tais resultados mostram o potencial que essa leguminosa apresenta como fornecedora de N para as plantas nos solos de terra firme da Amazônia Central.

Transferência de nitrogênio entre plantas interconectadas por fungos micorrízicos arbusculares (FMAS)

Este trabalho, desenvolvido em casa de vegetação da Universidade Estadual do Norte Fluminense (UENF), em Campos (RJ), no primeiro semestre de 1996, objetivou avaliar a importância dos fungos micorrízicos arbusculares (FMAS) no processo de transferência de N do feijão para o milho, utilizando o isótopo 15N. Foram construídos três tipos de vasos especiais, divididos em três seções, A, B e C, com 2 dm³ de capacidade: sem barreira, com tela de nylon de 40 ∝m (permitiu a passagem de hifas fúngicas, mas não a de raízes) e com tela de nylon de 1 ∝m (não permitiu a passagem de hifas e raízes) entre as seções B e C. Adicionaram-se 25 mg kg-1 de N somente na seção A de cada vaso, utilizando-se, como fonte (15NH4)2SO4. Duas plantas de feijão pré-germinadas e inoculadas com Rhizobium tropici foram plantadas com suas raízes divididas entre as seções A e B. Após 10 dias, efetuou-se o plantio do milho, diretamente, na seção C dos vasos, e a inoculação micorrízica nos tratamentos com o FMA foi feita pela adição de propágulos de Glomus etunicatum somente na seção C. O experimento foi coletado 35 dias após o transplantio do feijão, e os resultados demonstraram que a colonização micorrízica se mostrou satisfatória, tanto no milho quanto no feijão. A presença da micorriza aumentou a produção de matéria seca, conteúdo de 15N e P da parte aérea das plantas de milho. A transferência direta de 15N do feijão para o milho através do micélio fúngico foi de 16,6%; a transferência indireta envolvendo o FMA - ou seja, a absorção do 15N excretado pelas raízes do feijão na solução do solo que foi absorvido e transferido através do micélio do FMA para o milho - foi de 34,1%; e a transferência indireta não envolvendo o FMA - ou seja, a absorção de 15N pelas raízes de milho da solução do solo sem envolvimento do FMA - foi de 49,3%.

Fungo micorrízico, fósforo e nitrogênio no crescimento inicial da trema e do fedegoso

De março de 1993 a junho de 1994, em vasos com amostra de um latossolo vermelho-escuro (LE) argiloso fase cerrado, estudou-se a resposta da trema (Trema micrantha (L)Blum.) e do fedegoso (Senna macranthera Rich.) a fósforo (P) nitrogênio (N) e à inoculação com o fungo micorrízico arbuscular Glomus etunicatum (Ge) Becker & Gerdemann. O trabalho foi desenvolvido em casa de vegetação do Departamento de Ciência do Solo da Universidade Federal de Lavras (MG), por meio de dois experimentos. A inoculação com Ge resultou em efeitos positivos para o crescimento das espécies, sendo esse efeito menos evidente no fedegoso que se beneficiou mais dos fungos indígenas. Em plantas inoculadas, a dose de P necessária para atingir 80% do crescimento máximo (CM) foi de 100 mg kg-1 de P no solo, para a trema, e de 80 mg kg-1 de P no solo, para o fedegoso, enquanto as plantas colonizadas pelos fungos indígenas requereram, respectivamente, 3,2 e 1,5 vezes mais P para atingir tal crescimento. Ambas as espécies apresentaram crescimento reduzido na ausência de P, porém tiveram grande crescimento quando receberam superfosfato. Por outro lado, a adição de N mineral não promoveu o crescimento das mudas. A adição de P solúvel e a introdução de G. etunicatum são importantes fatores para o crescimento inicial das espécies estudadas, em solo de baixa fertilidade natural.